Objective: To investigate lifetime risk of total hip replacement surgery (THR) in the state of Victoria, Australia and describe temporal trends in THR incidence.
Significance & Innovation
• Estimation of the lifetime risk of joint replacement surgery is an emerging field in musculoskeletal epidemiology. Lifetime risk provides an alternative method to burden of disease data for quantifying population disease burden and associated healthcare utilisation.
For this study, lifetime risk of total hip replacement (THR) was used to estimate the probability of having surgery over an individual's lifetime.
• Lifetime risk of THR increased over the 9-year study period to 9.90% (95% CI:
9.60%-10.16%) for males and 10.27% (95% CI: 10.07%-10.49%) for females.
• The lifetime risk of THR for both sexes was similar, despite a higher burden of hip OA for females, warranting further investigation on barriers to accessing surgery. Increases in the number of procedures in regional areas and in lower socio-economic groups suggest reductions in known disparities over time.
Introduction
Estimation of the lifetime risk of joint replacement surgery is an emerging field in musculoskeletal epidemiology. While global burden of disease data are valuable for understanding disease incidence and prevalence and the relative impact of a disease on 2.2% to 6.6% for males.
Changes in lifetime risk of THR over time could be mediated by external environment (macro), health system (meso) and patient and clinician (micro) level factors ( Figure 1 ).
Environmental factors, such as changes in population demographics, due to the ageing population and the social acceptability of THR may play a role, as the procedure becomes more common and educational attainment across the population increases. 4 Inequitable access to joint replacement has been identified across a range of settings. 5 Our earlier research involving the lifetime risk of total knee replacement (TKR) suggested that policy initiatives to reduce barriers to accessing TKR increased the overall utilisation over the time period for some patient groups. 6 We identified a steady increase in the incidence of TKR in Victoria over the 9-year study period for private hospitals (overall increase of 90%), which may have been related to private health insurance initiatives introduced over the same time period to encourage higher rates of private health insurance, allowing more patients to access surgery through the private system. However, disparities for public patients were still also contribute to a rise in overall lifetime risk.
Whether similar patterns exist in relation to THR utilisation in Australia is unclear as only cross-sectional data have been reported to date. 10 Longitudinal investigation of THR incidence according to different system-level factors is fundamental for interpreting temporal changes in the lifetime risk of THR.
The present study aims to:
• investigate lifetime risk of THR in Victoria, Australia and temporal changes in risk; and
• describe temporal changes in the incidence of THR according to healthcare setting (public versus private), SES and geographical location of residence and hospital which could contribute to changes in lifetime risk. 
Methods

Data Sources
Participant inclusion criteria
The numerator for our study included patients with a hospital admission from 1 July 1998 to 30 June 2009 and an operative procedure code indicating a primary or bilateral THR (see Table 1 ). As we did not have data on the laterality of procedures, we excluded second primary THR procedures, if identified, over the time period (n=7188), as these were assumed to involve the contralateral hip. Patient transfers to other hospitals (n=434) and admissions including codes to indicate fractures to the neck of femur (n=1527) were also excluded.
Covariates of interest Our methods have been described previously. 12 In summary, age, gender, hospital type (public or private) and hospital region (metropolitan or rural) were extracted from the VAED.
Age at time of hospital admission for THR was categorised into ten-year groups. Patient comorbidities were defined using ICD-10-AM codes 13 (Appendix 1) and the primary diagnosis on admission was identified. We were not able include obesity among the comorbidities of interest, as the coding of this variable was considered to be incomplete. We found that only 1.52% of people receiving THR were obese, compared to Australian population data demonstrating that 20.5% of the general population are obese.
14 Hospital type was included as an indication of health insurance status. In Australia, THR is performed in both the public and private health systems. The public system is funded by the government and provides universal health care, but commonly has long waiting lists for surgery. The private health system is accessible to individuals with private health insurance and those who are able to pay the costs associated with treatment. In the context of THR, the private health system offers two main advantages for patients: choice of surgeon and avoidance of longer waits for consultation and surgery. . In Australia, rural residence has been linked to poorer health outcomes, as access to care can be more limited and rates of risk factors may be higher. 16 In contrast to our previous methods, 12 we utilised this method of classifying patients' rurality to allow us to determine whether patients who lived in rural areas were also receiving care at rural hospitals.
Each patient's SLA at the time of hospital admission was linked to the Australian SocioEconomic Indexes for Areas (SEIFA). 17 The SEIFA measure is an Australia-wide area based index of SES based on census data for each SLA. The Index of Economic Resources, one of four measures of SES, was utilised for this study. This composite index includes measures of income, employment and housing status within each geographical area. We selected this index of SES, as it was thought to most closely reflect economic capacity to purchase private health insurance, which allows faster access to THR surgery in Australia.
Where the SLA was missing (n=197 patients and 34 SLAs), we imputed the index of economic resource from SLAs within closest geographical proximity. Where adjacent SLAs differed in their indices of economic resources, we chose the closest SLA with the largest population.
Statistical analysis
Chi-square analyses were undertaken for comparisons between all categorical variables.
The lifetime risk of THR was calculated for each age group by dividing the total number of incident THRs by the total number of people expected to be alive at beginning of the time period based on the ABS all-cause mortality rates for the Victorian population. These methods have been described elsewhere. 12, 18 Lifetime risk within each ten-year age group and overall lifetime risk were calculated at three time periods (1999-2000, 2003-2004, 2007-2008 ) and stratified by gender. Confidence intervals (95%) were calculated using a Poisson model, as recommended for rate-based analyses. 19 We calculated the incidence of THR for each financial year (1 July to 30 June) within the study period according to health care setting (public v private), SES, residential location and hospital location (metropolitan v rural). The population data used for SES has been previously described. 6 All statistical analyses were performed using Microsoft Excel 2010 
Results
Characteristics of the cohort
We identified 45,775 patients with a hospital episode including a primary THR procedure over the study period (Table 1) 
Lifetime risk of primary total hip replacement
We examined the lifetime risk of THR at three time points 
Discussion
Over the 11-year period examined in this study, we quantified the lifetime risk of THR in the second largest state in Australia (accounting for 20% of the population). 20 We also characterised changes in THR utilisation according to different system-level factors which could theoretically impact lifetime risk of surgery. There was a significant increase in the lifetime risk of THR for both genders, although this trend was sharper for females. Despite this, our overall lifetime risk estimates were relatively similar for both genders. As the prevalence of hip OA is known to be higher in females compared to males in Australia, 21 this difference may indicate under-utilisation of surgery by females and warrants further investigation. We also noted increasing utilisation in private hospitals and for patients both residing in rural areas and being treated in rural areas. THR incidence increased in the middle and lowest socio-economic groups, while the highest remained steady, suggesting improved access to surgery over time for the lower two groups.
Our lifetime risk estimates for THR for men from age 50-59 were relatively consistent with estimates reported by Culliford et al 3 in the UK but significantly lower for women in this age group. When considering overall lifetime risk from age 20-29, our estimates for women are comparable with the UK data, suggesting women may be receiving THR at younger ages in
Australia. This may relate to gender and age-related differences in diagnosis and uptake of THR between countries. 22 Exploring international patterns of lifetime THR risk could help to identify the contribution of patient-level factors, such as OA and obesity burden, and differences in health policies and surgical practices (figure 1). The increased trends in the lifetime risk of THR identified in this study were similar to those identified in our previous study examining the lifetime risk of TKR; 6 however, TKR utilisation patterns demonstrated a greater increase than THR over the time period. In the previous study, we also noted an increase in TKRs in regional settings, suggesting this may relate to system-wide changes.
Encouragingly, we observed an increasing trend in THRs for the lowest SES group; this is in contrast to the reducing incidence of TKRs for this group over a similar time period and surgical prioritisation system to reduce waiting times for orthopaedic assessment and surgery and facilitate faster access to care for people with the greatest need. 25 It is now part of routine standard care in Victorian public hospitals. The increase in the number of THRs performed on rural patients may be related to workforce initiatives to increase the number of orthopaedic surgeons in regional areas, however, the trend was also seen among rural patients receiving care in metropolitan hospitals, so may reflect greater need among rural patients. Variation in the rates of orthopaedic procedures in different geographical areas has been documented elsewhere, which may be related to differences in indications and clinical decision-making for surgery in different settings. 10, 26 There are several limitations to this study which should be acknowledged. This study relied primarily on health system administrative data. These data were collected primarily for hospital reimbursement purposes, so detailed clinical information, such as the laterality of the procedures, was not available. While this would not change our estimates of overall lifetime risk, we may have overestimated the patient's age at first primary THR if a prior procedure had been conducted on the contralateral hip. As ages were provided to us in groupings (with 80 plus being the highest category), we were not able to examine the lifetime risk for patients aged 80-89. We also excluded procedures conducted for fractured neck of femurs; however, these accounted for only 3.3% of total THR procedures. There were 0.4% of cases with missing SLA data, where we imputed SES using nearest neighbour imputation methods. 27 Given the small number of cases, these are unlikely to change our estimates.
Data on some patient comorbidities, such as obesity, were well below population averages and thought to be underreported in our data, so we were unable to use these in our analyses. Finally, we based this study on data from one Australian state. As the population of Victoria accounts for 20% of the Australian population, it is reasonable to expect the Victorian data to be representative of other large Australian states. However, the statebased policy initiatives we described to improve access to THR during the study period may have produced local trends.
Conclusion
We identified an increase in the lifetime risk of THR for both men and women over the 11-year study period. The observed increases in the number of procedures performed for patients in regional areas and in lower socio-economic groups are encouraging and suggest some reductions over time in known disparities. However, the lifetime risk of THR performed on women is similar to males, despite a higher burden of hip OA, and warrants further investigation. * Lifetime Risk calculations have been undertaken separately for males and females based on the gender-specific values for survival (S) and risk of undergoing a THR (R) at age X, using the formula Incidence per 1000 population Incidence per 1000 population
Incidence per 1000 population
